HomeInsightsMarket Capitalization

Market Capitalization of Bliss Gvs Pharma Ltd

Market Capitalization of Bliss Gvs Pharma Ltd

stocks purchased

₹ 0.6 Cr

Volume Transacted

(Dec 26, 2024)

stocks purchased

38.4 K

Stocks Traded

(Dec 26, 2024)

Last Updated on: Dec 26, 2024

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

Market Cap

₹ 1708.51 crore

Last updated on: Dec 26, 2024

Key Highlights

  • The Market Cap of Bliss GVS Pharma Ltd is ₹ 1708 crore as of 26 Dec 24 .
  • The Market Cap of Bliss GVS Pharma Ltd changed from ₹ 1856 crore on March 2019 to ₹ 1179 crore on March 2024 . This represents a CAGR of -7.28% over 6 years.
  • The Latest Trading Price of Bliss GVS Pharma Ltd is ₹ 162.15 as of 26 Dec 15:30 .
  • The dividend payouts of Bliss GVS Pharma Ltd changed from ₹ 1 to ₹ 0.5 over 6 quarters. This represents a CAGR of -37.00% .

Historical Market Cap of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Bliss GVS Pharma Ltd

No data available

Image

Bliss GVS Pharma Ltd

NSE: BLISSGVS

Share Price

₹ 162.15

2.25 (1.41%)

stock direction

Last updated on: Dec 26, 2024

Market Price of Bliss GVS Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Bliss GVS Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
26 Dec 2024162.15
24 Dec 2024159.9
23 Dec 2024158.85
20 Dec 2024161.35
19 Dec 2024170.1
18 Dec 2024167.35
17 Dec 2024167.9
16 Dec 2024175.7
13 Dec 2024175.85
12 Dec 2024173.8

SWOT Analysis Of Bliss GVS Pharma Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Bliss GVS Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Bliss GVS Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Bliss GVS Pharma Ltd

No data available

No data available

Historical P/E Ratio of Bliss GVS Pharma Ltd

No data available

* All values are in %

Historical Revenue of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Bliss GVS Pharma Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Bliss GVS Pharma Ltd

No data available

* All values are in

About Bliss GVS Pharma Ltd

  • Bliss GVS Pharma Limited was originally incorporated as a Private Limited Company in the name of Bliss Chemicals & Pharmaceuticals India Private Limited in 1984.
  • The status converted into a Public Limited Company and the name of the Company was changed to Bliss Chemicals & Pharmaceuticals India Limited and further to Bliss GVS Pharma Limited on May 12, 2006. The Company, founded in 1984 with the objective of ensuring healthcare access worldwide, is one of the pharmaceutical industries' fastest-growing businesses.
  • The Company has a robust portfolio of more than 250 products and is a global leader in the dosage forms for suppositories and pessaries.
  • It has a strong foothold in Sub Saharan Africa.
  • The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products.

Bliss GVS Pharma Ltd News Hub

News

Bliss GVS Pharma allots 34,250 equity shares under ESOP

Bliss GVS Pharma has allotted 34,250 equity shares under ESOP on 06 December 2024. With th...

Read more

06 Dec 2024 19:02

News

Bliss GVS Pharma soars after manufacturing units get GMP certificate from Romania medical authority

In a regulatory filing made on Saturday, the company informed that its manufacturing facil...

Read more

25 Nov 2024 09:40

News

Bliss GVS Pharma's manufacturing facilities complete EU GMP inspection

Bliss GVS Pharma announced that the company's manufacturing facility situated at Plot No. ...

Read more

23 Nov 2024 15:02

News

Bliss GVS Pharma to table results

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 Octobe...

Read more

18 Oct 2024 10:48

News

Bliss GVS Pharma allots 1.57 lakh equity shares under ESOP

Bliss GVS Pharma has allotted 157,550 equity shares under ESOP on 04 October 2024. With th...

Read more

04 Oct 2024 18:37

News

Bliss GVS Pharma to convene board meeting

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 24 July 2...

Read more

18 Jul 2024 11:35

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Bliss GVS Pharma Ltd Market Cap

What is the market cap of Bliss GVS Pharma Ltd?

As of December 26, 2024, Bliss GVS Pharma Ltd has a market capitalization of ₹1708.51, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Bliss GVS Pharma Ltd's market capitalization?

Bliss GVS Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Bliss GVS Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Bliss GVS Pharma Ltd's market capitalization change?

Bliss GVS Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions